Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 19;13(6):1395.
doi: 10.3390/cancers13061395.

Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives

Affiliations
Review

Large Scale Molecular Studies of Pituitary Neuroendocrine Tumors: Novel Markers, Mechanisms and Translational Perspectives

Raitis Peculis et al. Cancers (Basel). .

Abstract

Pituitary neuroendocrine tumors (PitNETs) are non-metastatic neoplasms of the pituitary, which overproduce hormones leading to systemic disorders, or tumor mass effects causing headaches, vertigo or visual impairment. Recently, PitNETs have been investigated in large scale (exome and genome) molecular analyses (transcriptome microarrays and sequencing), to uncover novel markers. We performed a literature analysis on these studies to summarize the research data and extrapolate overlapping gene candidates, biomarkers, and molecular mechanisms. We observed a tendency in samples with driver mutations (GNAS, USP8) to have a smaller overall mutational rate, suggesting driver-promoted tumorigenesis, potentially changing transcriptome profiles in tumors. However, direct links from drivers to signaling pathways altered in PitNETs (Notch, Wnt, TGF-β, and cell cycle regulators) require further investigation. Modern technologies have also identified circulating nucleic acids, and pinpointed these as novel PitNET markers, i.e., miR-143-3p, miR-16-5p, miR-145-5p, and let-7g-5p, therefore these molecules must be investigated in the future translational studies. Overall, large-scale molecular studies have provided key insight into the molecular mechanisms behind PitNET pathogenesis, highlighting previously reported molecular markers, bringing new candidates into the research field, and reapplying traditional perspectives to newly discovered molecular mechanisms.

Keywords: large scale molecular analysis; molecular markers; pituitary neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of main “omics” studies in PitNETs grouped by investigated nucleic acid type. The top part shows the most popular study designs by molecule type. The middle section represents the most common methods, with next-generation sequencing having a central role in the investigation of PitNET nucleic acids nowadays. The selection of main discoveries is displayed in the lower part of the figure with the colour encoding of the nucleic acid origin, signalling pathways or related description of the relation of the discoveries to certain study design.

Similar articles

Cited by

References

    1. Daly A.F., Rixhon M., Adam C., Dempegioti A., Tichomirowa M.A., Beckers A. High prevalence of pituitary adenomas: A cross-sectional study in the province of Liège, Belgium. J. Clin. Endocrinol. Metab. 2006;91:4769–4775. doi: 10.1210/jc.2006-1668. - DOI - PubMed
    1. Schneider H.J., Sievers C., Saller B., Wittchen H.U., Stalla G.K. High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin. Endocrinol. (Oxf.) 2008;69:432–435. doi: 10.1111/j.1365-2265.2008.03221.x. - DOI - PubMed
    1. Rosario P.W., Calsolari M.R. Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary. 2012;15:179–183. doi: 10.1007/s11102-011-0302-7. - DOI - PubMed
    1. Ntali G., Wass J.A. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary. 2018;21:111–118. doi: 10.1007/s11102-018-0869-3. - DOI - PubMed
    1. Aflorei E.D., Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas. J. Neurooncol. 2014;117:379–394. doi: 10.1007/s11060-013-1354-5. - DOI - PubMed

LinkOut - more resources